KPTI Karyopharm Therapeutics1.88-0.06 (-3.1%)
KPTI Karyopharm Therapeutics1.99+0.03 (+1.5%)
KPTI Karyopharm Therapeutics2.28-4.73 (-67.5%)
Premarket Decliner
KPTI Karyopharm Therapeutics7.01+0.15+2.2%
Premarket:2.31-4.70 (-67.1%)
Karyopharm Plans to Submit sNDA for Selinexor Plus Ruxolitinib in Myelofibrosis Under Accelerated Approval Pathway
PRNewswireThu, 30-Jul 4:06 PM
KPTI Karyopharm Therapeutics8.13-1.38 (-14.5%)